ArticleThe oncologist2023

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.

Kimberly Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.